» Articles » PMID: 26752947

Malignant Biliary Obstruction: the Current Role of Interventional Radiology

Overview
Specialty Gastroenterology
Date 2016 Jan 12
PMID 26752947
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cholangiocarcinoma and pancreatic head cancer are still linked with extremely high 5-year mortality in the western world. The management of such patients is complex and typically requires a multidisciplinary approach in a tertiary care center. Interventional radiology offers minimally invasive, image-guided treatment for a variety of diseases and conditions. Regarding patients with malignant biliary obstruction, IR options are considered for more than two decades as a valid management tool for both operable and non-operable cases. The options include placement of percutaneous transhepatic biliary drains, preoperative embolization of the portal vein and deployment of covered and uncovered biliary stents. The purpose of this review is to describe the current evidence in this continuously evolving field.

Citing Articles

Diagnostic investigation, intervention, and outcome for post-subtotal gastrectomy patients who present with jaundice.

Wang D, Zhu L, Kong F, Pan Y, Liu W, Wang X Front Med (Lausanne). 2025; 12:1485442.

PMID: 40012969 PMC: 11860952. DOI: 10.3389/fmed.2025.1485442.


Efficacy and safety of endoscopic ultrasonography (EUS) hepaticogastrostomy (HGS) versus choledochoduodenostomy (CDS) in ERCP-failed malignant biliary obstruction: A systematic review and META-analysis.

Rizqiansyah C, Awatara P, Amar N, Lesmana C, Mustika S JGH Open. 2024; 8(10):e70037.

PMID: 39439478 PMC: 11494398. DOI: 10.1002/jgh3.70037.


The efficacy of the combination of percutaneous transhepatic biliary drainage and I stranded seeds for malignant bile duct obstruction treatment.

Li S, Li B, Li L, Yang X, Xu F, Wang W J Contemp Brachytherapy. 2020; 12(3):225-232.

PMID: 32695193 PMC: 7366027. DOI: 10.5114/jcb.2020.96862.


A newly designed uncovered biliary stent for palliation of malignant obstruction: results of a prospective study.

Lawrence C, Nieto J, Parsons W, Roy A, Guda N, Steinberg S BMC Gastroenterol. 2020; 20(1):184.

PMID: 32522161 PMC: 7288422. DOI: 10.1186/s12876-020-01325-9.


Transjugular insertion of biliary stent in patients with malignant biliary obstruction complicated by ascites with/without coagulopathy: a prospective study of 12 patients.

Shim D, Gwon D, Ko G, Yoon H, Sung K Diagn Interv Radiol. 2019; 25(6):465-470.

PMID: 31650963 PMC: 6837303. DOI: 10.5152/dir.2019.18470.


References
1.
Knyrim K, Wagner H, Pausch J, Vakil N . A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy. 1993; 25(3):207-12. DOI: 10.1055/s-2007-1010294. View

2.
Yee A, Ho C . Complications of percutaneous biliary drainage: benign vs malignant diseases. AJR Am J Roentgenol. 1987; 148(6):1207-9. DOI: 10.2214/ajr.148.6.1207. View

3.
Kanasaki S, Furukawa A, Kane T, Murata K . Polyurethane-covered Nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction. Cardiovasc Intervent Radiol. 2000; 23(2):114-20. DOI: 10.1007/s002709910023. View

4.
Bezzi M, Zolovkins A, Cantisani V, Salvatori F, Rossi M, Fanelli F . New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction. J Vasc Interv Radiol. 2002; 13(6):581-9. DOI: 10.1016/s1051-0443(07)61651-0. View

5.
Silvis S, Sievert Jr C, VENNES J, Abeyta B, Brennecke L . Comparison of covered versus uncovered wire mesh stents in the canine biliary tract. Gastrointest Endosc. 1994; 40(1):17-21. DOI: 10.1016/s0016-5107(94)70004-4. View